Lilly has had a significant presence in Europe since our first overseas subsidiary was established in the UK in 1934. Today we have major research sites in Europe, and our European manufacturing sites are important exporters to other parts of the world. Our UK site, Erl Wood, is Lilly's biggest research operation outside of the US. Across the globe and here in Europe, Lilly has developed productive alliances and partnerships that advance our capacity to develop innovative medicines at lower costs. We discover and develop products through rigorous testing and in accordance with the highest scientific and ethical standards, and we strive to create products that fulfil the clinical promise of their Lilly label.